The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and liquid-based cytology (LBC) as primary screening tests. Each woman with a positive result received colposcopy with lesion-ta...
Main Authors: | Shao-Kai Zhang, Zhen Guo, Peng Wang, Le-Ni Kang, Man-Man Jia, Ze-Ni Wu, Qiong Chen, Xiao-Qin Cao, Dong-Mei Zhao, Pei-Pei Guo, Xi-Bin Sun, Jian-Gong Zhang, You-Lin Qiao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.533253/full |
Similar Items
-
Parents’ Knowledge and Attitude towards HPV and HPV Vaccination in Poland
by: Katarzyna Smolarczyk, et al.
Published: (2022-02-01) -
Persistent HPV infection after conization of cervical intraepithelial neoplasia—— a systematic review and meta-analysis
by: Yueyang Zhang, et al.
Published: (2023-05-01) -
Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
by: Zhi-Fang Li, et al.
Published: (2022-11-01) -
Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
by: Baozhu Yi, et al.
Published: (2022-05-01) -
Effect of Condom Use after CIN Treatment on Cervical HPV Biomarkers Positivity: Prolonged Follow Up Study
by: George Valasoulis, et al.
Published: (2022-07-01)